View Item 

Show simple item record

Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation
dc.contributor.authorFenske, Timothy S.
dc.contributor.authorAhn, Kwang W.
dc.contributor.authorGraff, Tara M.
dc.contributor.authorDiGilio, Alyssa
dc.contributor.authorBashir, Qaiser
dc.contributor.authorKamble, Rammurti T.
dc.contributor.authorAyala, Ernesto
dc.contributor.authorBacher, Ulrike
dc.contributor.authorBrammer, Jonathan E.
dc.contributor.authorCairo, Mitchell
dc.contributor.authorChen, Andy
dc.contributor.authorChen, Yi‐bin
dc.contributor.authorChhabra, Saurabh
dc.contributor.authorD’Souza, Anita
dc.contributor.authorFarooq, Umar
dc.contributor.authorFreytes, Cesar
dc.contributor.authorGanguly, Siddhartha
dc.contributor.authorHertzberg, Mark
dc.contributor.authorInwards, David
dc.contributor.authorJaglowski, Samantha
dc.contributor.authorKharfan‐dabaja, Mohamed A.
dc.contributor.authorLazarus, Hillard M.
dc.contributor.authorNathan, Sunita
dc.contributor.authorPawarode, Attaphol
dc.contributor.authorPerales, Miguel‐angel
dc.contributor.authorReddy, Nishitha
dc.contributor.authorSeo, Sachiko
dc.contributor.authorSureda, Anna
dc.contributor.authorSmith, Sonali M.
dc.contributor.authorHamadani, Mehdi
dc.date.accessioned2016-09-17T23:54:51Z
dc.date.available2017-10-05T14:33:48Zen
dc.date.issued2016-07
dc.identifier.citationFenske, Timothy S.; Ahn, Kwang W.; Graff, Tara M.; DiGilio, Alyssa; Bashir, Qaiser; Kamble, Rammurti T.; Ayala, Ernesto; Bacher, Ulrike; Brammer, Jonathan E.; Cairo, Mitchell; Chen, Andy; Chen, Yi‐bin ; Chhabra, Saurabh; D’Souza, Anita; Farooq, Umar; Freytes, Cesar; Ganguly, Siddhartha; Hertzberg, Mark; Inwards, David; Jaglowski, Samantha; Kharfan‐dabaja, Mohamed A. ; Lazarus, Hillard M.; Nathan, Sunita; Pawarode, Attaphol; Perales, Miguel‐angel ; Reddy, Nishitha; Seo, Sachiko; Sureda, Anna; Smith, Sonali M.; Hamadani, Mehdi (2016). "Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation." British Journal of Haematology 174(2): 235-248.
dc.identifier.issn0007-1048
dc.identifier.issn1365-2141
dc.identifier.urihttps://hdl.handle.net/2027.42/133605
dc.publisherWiley Periodicals, Inc.
dc.subject.otherprior autologous transplan
dc.subject.otherallogeneic transplantation
dc.subject.otherprognostic score
dc.subject.otherDLBCL
dc.titleAllogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelOncology and Hematology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/133605/1/bjh14046.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/133605/2/bjh14046_am.pdf
dc.identifier.doi10.1111/bjh.14046
dc.identifier.sourceBritish Journal of Haematology
dc.identifier.citedreferenceBacigalupo, A., Ballen, K., Rizzo, D., Giralt, S., Lazarus, H., Ho, V., Apperley, J., Slavin, S., Pasquini, M., Sandmaier, B.M., Barrett, J., Blaise, D., Lowski, R. & Horowitz, M. ( 2009 ) Defining the intensity of conditioning regimens: working definitions. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation, 15, 1628 â 1633.
dc.identifier.citedreferenceBachanova, V., Burns, L.J., Ahn, K.W., Laport, G.G., Akpek, G., Kharfanâ Dabaja, M.A., Nishihori, T., Agura, E., Armand, P., Jaglowski, S.M., Cairo, M.S., Cashen, A.F., Cohen, J.B., D’Souza, A., Freytes, C.O., Gale, R.P., Ganguly, S., Ghosh, N., Holmberg, L.A., Inwards, D.J., Kanate, A.S., Lazarus, H.M., Malone, A.K., Munker, R., Mussetti, A., Norkin, M., Prestidge, T.D., Rowe, J.M., Satwani, P., Siddiqi, T., Stiff, P.J., William, B.M., Wirk, B., Maloney, D.G., Smith, S.M., Sureda, A.M., Carreras, J. & Hamadani, M. & Center for International Blood and Marrow Transplant Research Lymphoma Working Committee. ( 2015 ) Impact of pretransplantation (18)Fâ fluorodeoxy glucoseâ positron emission tomography status on outcomes after allogeneic hematopoietic cell transplantation for nonâ hodgkin lymphoma. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation, 21, 1605 â 1611.
dc.identifier.citedreferencePrzepiorka, D., Weisdorf, D., Martin, P., Klingemann, H.G., Beatty, P., Hows, J. & Thomas, E.D. ( 1995 ) 1994 consensus conference on acute GVHD grading. Bone Marrow Transplantation, 15, 825 â 828.
dc.identifier.citedreferencePhilip, T., Guglielmi, C., Hagenbeek, A., Somers, R., Van der Lelie, H., Bron, D., Sonneveld, P., Gisselbrecht, C., Cahn, J.Y. & Harousseau, J.L. ( 1995 ) Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapyâ sensitive nonâ hodgkin’s lymphoma. The New England Journal of Medicine, 333, 1540 â 1545.
dc.identifier.citedreferenceMounier, N., Canals, C., Gisselbrecht, C., Cornelissen, J., Foa, R., Conde, E., Maertens, J., Attal, M., Rambaldi, A., Crawley, C., Luan, J.J., Brune, M., Wittnebel, S., Cook, G., van Imhoff, G.W., Pfreundschuh, M. & Sureda, A. & Lymphoma Working Party of European Blood and Marrow Transplantation Registry (EBMT). ( 2012 ) Highâ dose therapy and autologous stem cell transplantation in first relapse for diffuse large B cell lymphoma in the rituximab era: an analysis based on data from the european blood and marrow transplantation registry. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation, 18, 788 â 793.
dc.identifier.citedreferenceMoskowitz, C.H., Zelenetz, A.D., Kewalramani, T., Hamlin, P., Lessacâ Chenen, S., Houldsworth, J., Olshen, A., Chaganti, R., Nimer, S. & Teruyaâ Feldstein, J. ( 2005 ) Cell of origin, germinal center versus nongerminal center, determined by immunohistochemistry on tissue microarray, does not correlate with outcome in patients with relapsed and refractory DLBCL. Blood, 106, 3383 â 3385.
dc.identifier.citedreferenceKlyuchnikov, E., Bacher, U., Kroll, T., Shea, T.C., Lazarus, H.M., Bredeson, C. & Fenske, T.S. ( 2014 ) Allogeneic hematopoietic cell transplantation for diffuse large B cell lymphoma: who, when and how? Bone Marrow Transplantation, 49, 1 â 7.
dc.identifier.citedreferenceKim, J.W., Kim, S.W., Tada, K., Fukuda, T., Lee, J.H., Lee, J.J., Kwon, J.H., Bang, S.M., Kim, I., Yoon, S.S., Lee, J.S. & Park, S. ( 2014 ) Allogeneic stem cell transplantation in patients with de novo diffuse large Bâ cell lymphoma who experienced relapse or progression after autologous stem cell transplantation: a koreaâ japan collaborative study. Annals of Hematology, 93, 1345 â 1351.
dc.identifier.citedreferencevan Kampen, R.J., Canals, C., Schouten, H.C., Nagler, A., Thomson, K.J., Vernant, J.P., Buzyn, A., Boogaerts, M.A., Luan, J.J., Maury, S., Milpied, N.J., Jouet, J.P., Ossenkoppele, G.J. & Sureda, A. ( 2011 ) Allogeneic stemâ cell transplantation as salvage therapy for patients with diffuse large Bâ cell nonâ hodgkin’s lymphoma relapsing after an autologous stemâ cell transplantation: an analysis of the european group for blood and marrow transplantation registry. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 29, 1342 â 1348.
dc.identifier.citedreferenceHamadani, M., Hari, P.N., Zhang, Y., Carreras, J., Akpek, G., Aljurf, M.D., Ayala, E., Bachanova, V., Chen, A.I., Chen, Y.B., Costa, L.J., Fenske, T.S., Freytes, C.O., Ganguly, S., Hertzberg, M.S., Holmberg, L.A., Inwards, D.J., Kamble, R.T., Kanfer, E.J., Lazarus, H.M., Marks, D.I., Nishihori, T., Olsson, R., Reddy, N.M., Rizzieri, D.A., Savani, B.N., Solh, M., Vose, J.M., Wirk, B., Maloney, D.G., Smith, S.M., Montoto, S., Saber, W., Alpdogan, O., Cashen, A., Dandoy, C., Finke, R., Gale, R., Gibson, J., Hsu, J.W., Janakiraman, N., Laughlin, M.J., Lill, M., Cairo, M.S., Munker, R., Rowlings, P.A., Schouten, H.C., Shea, T.C., Stiff, P.J. & Waller, E.K. ( 2014 ) Early failure of frontline rituximabâ containing chemoâ immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation, 20, 1729 â 1736.
dc.identifier.citedreferenceHamadani, M., Saber, W., Ahn, K.W., Carreras, J., Cairo, M.S., Fenske, T.S., Gale, R.P., Gibson, J., Hale, G.A., Hari, P.N., Hsu, J.W., Inwards, D.J., Kamble, R.T., Klein, A., Maharaj, D., Marks, D.I., Rizzieri, D.A., Savani, B.N., Schouten, H.C., Waller, E.K., Wirk, B., Laport, G.G., Montoto, S., Maloney, D.G. & Lazarus, H.M. ( 2013 ) Impact of pretransplantation conditioning regimens on outcomes of allogeneic transplantation for chemotherapyâ unresponsive diffuse large B cell lymphoma and grade III follicular lymphoma. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation, 19, 746 â 753.
dc.identifier.citedreferenceGu, K., Weisenburger, D.D., Fu, K., Chan, W.C., Greiner, T.C., Aoun, P., Smith, L.M., Bast, M., Liu, Z., Bociek, R.G., Bierman, P.J., Armitage, J.O. & Vose, J.M. ( 2012 ) Cell of origin fails to predict survival in patients with diffuse large Bâ cell lymphoma treated with autologous hematopoietic stem cell transplantation. Hematological Oncology, 30, 143 â 149.
dc.identifier.citedreferenceGisselbrecht, C., Glass, B., Mounier, N., Singh Gill, D., Linch, D.C., Trneny, M., Bosly, A., Ketterer, N., Shpilberg, O., Hagberg, H., Ma, D., Briere, J., Moskowitz, C.H. & Schmitz, N. ( 2010 ) Salvage regimens with autologous transplantation for relapsed large Bâ cell lymphoma in the rituximab era. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 28, 4184 â 4190.
dc.identifier.citedreferenceFenske, T.S., Hari, P.N., Carreras, J., Zhang, M.J., Kamble, R.T., Bolwell, B.J., Cairo, M.S., Champlin, R.E., Chen, Y.B., Freytes, C.O., Gale, R.P., Hale, G.A., Ilhan, O., Khoury, H.J., Lister, J., Maharaj, D., Marks, D.I., Munker, R., Pecora, A.L., Rowlings, P.A., Shea, T.C., Stiff, P., Wiernik, P.H., Winter, J.N., Rizzo, J.D., van Besien, K., Lazarus, H.M. & Vose, J.M. ( 2009 ) Impact of preâ transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation, 15, 1455 â 1464.
dc.identifier.citedreferenceBishop, M.R., Dean, R.M., Steinberg, S.M., Odom, J., Pavletic, S.Z., Chow, C., Pittaluga, S., Sportes, C., Hardy, N.M., Geaâ Banacloche, J., Kolstad, A., Gress, R.E. & Fowler, D.H. ( 2008 ) Clinical evidence of a graftâ versusâ lymphoma effect against relapsed diffuse large Bâ cell lymphoma after allogeneic hematopoietic stemâ cell transplantation. Annals of Oncology: Official Journal of the European Society for Medical Oncology/ESMO, 19, 1935 â 1940.
dc.identifier.citedreferenceBacher, U., Klyuchnikov, E., Leâ Rademacher, J., Carreras, J., Armand, P., Bishop, M.R., Bredeson, C.N., Cairo, M.S., Fenske, T.S., Freytes, C.O., Gale, R.P., Gibson, J., Isola, L.M., Inwards, D.J., Laport, G.G., Lazarus, H.M., Maziarz, R.T., Wiernik, P.H., Schouten, H.C., Slavin, S., Smith, S.M., Vose, J.M., Waller, E.K. & Hari, P.N. & Lymphoma Working Committee of the CIBMTR. ( 2012 ) Conditioning regimens for allotransplants for diffuse large Bâ cell lymphoma: Myeloablative or reduced intensity? Blood, 120, 4256 â 4262.
dc.identifier.citedreferenceZhang, X. & Zhang, M.J. ( 2011 ) SAS macros for estimation of direct adjusted cumulative incidence curves under proportional subdistribution hazards models. Computer Methods and Programs in Biomedicine, 101, 87 â 93.
dc.identifier.citedreferenceWeisdorf, D., Spellman, S., Haagenson, M., Horowitz, M., Lee, S., Anasetti, C., Setterholm, M., Drexler, R., Maiers, M., King, R., Confer, D. & Klein, J. ( 2008 ) Classification of HLAâ matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation, 14, 748 â 758.
dc.identifier.citedreferenceUrbanoâ Ispizua, A., Pavletic, S.Z., Flowers, M.E., Klein, J.P., Zhang, M.J., Carreras, J., Montoto, S., Perales, M.A., Aljurf, M.D., Akpek, G., Bredeson, C.N., Costa, L.J., Dandoy, C., Freytes, C.O., Fung, H.C., Gale, R.P., Gibson, J., Hamadani, M., Hayashi, R.J., Inamoto, Y., Inwards, D.J., Lazarus, H.M., Maloney, D.G., Martino, R., Munker, R., Nishihori, T., Olsson, R.F., Rizzieri, D.A., Reshef, R., Saad, A., Savani, B.N., Schouten, H.C., Smith, S.M., Socie, G., Wirk, B., Yu, L.C. & Saber, W. ( 2015 ) The impact of graftâ versusâ host disease on the relapse rate in patients with lymphoma depends on the histological subtype and the intensity of the conditioning regimen. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation, 21, 1746 â 1753.
dc.identifier.citedreferenceZhang, X., Loberiza, F.R., Klein, J.P. & Zhang, M.J. ( 2007 ) A SAS macro for estimation of direct adjusted survival curves based on a stratified cox regression model. Computer Methods and Programs in Biomedicine, 88, 95 â 101.
dc.identifier.citedreferenceThomson, K.J., Morris, E.C., Bloor, A., Cook, G., Milligan, D., Parker, A., Clark, F., Yung, L., Linch, D.C., Chakraverty, R., Peggs, K.S. & Mackinnon, S. ( 2009 ) Favorable longâ term survival after reducedâ intensity allogeneic transplantation for multipleâ relapse aggressive nonâ hodgkin’s lymphoma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 27, 426 â 432.
dc.identifier.citedreferenceThieblemont, C., Briere, J., Mounier, N., Voelker, H.U., Cuccuini, W., Hirchaud, E., Rosenwald, A., Jack, A., Sundstrom, C., Cogliatti, S., Trougouboff, P., Boudova, L., Ysebaert, L., Soulier, J., Chevalier, C., Bron, D., Schmitz, N., Gaulard, P., Houlgatte, R. & Gisselbrecht, C. ( 2011 ) The germinal center/activated Bâ cell subclassification has a prognostic impact for response to salvage therapy in relapsed/refractory diffuse large Bâ cell lymphoma: a bioâ CORAL study. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 29, 4079 â 4087.
dc.identifier.citedreferenceSirvent, A., Dhedin, N., Michallet, M., Mounier, N., Faucher, C., Yakoubâ Agha, I., Mohty, M., Robin, M., Tabrizi, R., Clement, L., Bilger, K., Larosa, F., Contentin, N., Huyn, A., Francois, S., Bulabois, C.E., Ceballos, P., Bourrhis, J.H., Buzyn, A., Cornillon, J., Guillerm, G., de Revel, T., Bay, J.O., Guilhot, F. & Milpied, N. ( 2010 ) Low nonrelapse mortality and prolonged longâ term survival after reducedâ intensity allogeneic stem cell transplantation for relapsed or refractory diffuse large B cell lymphoma: report of the societe francaise de greffe de moelle et de therapie cellulaire. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation, 16, 78 â 85.
dc.identifier.citedreferenceShulman, H.M., Sullivan, K.M., Weiden, P.L., McDonald, G.B., Striker, G.E., Sale, G.E., Hackman, R., Tsoi, M.S., Storb, R. & Thomas, E.D. ( 1980 ) Chronic graftâ versusâ host syndrome in man. A longâ term clinicopathologic study of 20 seattle patients. The American Journal of Medicine, 69, 204 â 217.
dc.identifier.citedreferenceRigacci, L., Puccini, B., Dodero, A., Iacopino, P., Castagna, L., Bramanti, S., Ciceri, F., Fanin, R., Rambaldi, A., Falda, M., Milone, G., Guidi, S., Martelli, M.F., Mazza, P., Oneto, R. & Bosi, A. & Gruppo Italiano Trapianto di Midollo Osseo (GITMO). ( 2012 ) Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study. Annals of Hematology, 91, 931 â 939.
dc.identifier.citedreferenceRezvani, A.R., Norasetthada, L., Gooley, T., Sorror, M., Bouvier, M.E., Sahebi, F., Agura, E., Chauncey, T., Maziarz, R.T., Maris, M., Shizuru, J., Bruno, B., Bredeson, C., Lange, T., Yeager, A., Sandmaier, B.M., Storb, R.F. & Maloney, D.G. ( 2008 ) Nonâ myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large Bâ cell lymphoma: a multicentre experience. British Journal of Haematology, 143, 395 â 403.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
bjh14046.pdf
Size:
235.8KB
Format:
PDF
View/Open
Name:
bjh14046_am.pdf
Size:
372.9KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.